| Gonzalez, Brian D |
H. Lee Moffitt Cancer Ctr & Res Inst
United States |
Impact of Targeted Therapy on Cancer-Related Cognitive Impairment |
1R01CA287666-01A1 |
|
|
| Goode, Diana J |
University Of New England
United States |
Novel expression of MHC class II on DRG neurons and its role in promoting antinociceptive CD4+ T cells in females during chemotherapy-induced peripheral neuropathy |
5R01CA267554-03 |
|
Rachel Altshuler, Ph.D. |
| Grady, William Mallory |
Fred Hutchinson Cancer Center
United States |
Biomarkers for optimizing risk prediction and early detection of cancers of the colon and esophagus |
5U2CCA271902-03 |
|
Matthew Young, Ph.D. |
| Grady, William Mallory |
Fred Hutchinson Cancer Center
United States |
Identifying Gut Microbial Inducers of Biological Aging in the Colon |
3U54CA274374-03S4 |
|
Christos Patriotis, Ph.D., M.Sc. |
| Grimm, Lars J |
Duke University
United States |
Dynamic imaging and tissue biomarker models to delineate indolent from aggressive breast calcifications |
5R01CA271237-03 |
PAR-19-264 (R01 Clinical Trial Optional) |
Richard Mazurchuk, Ph.D. |
| Grogan, Eric L |
Vanderbilt University Medical Center
United States |
Clinical Utility of Biomarkers Driven Management of Indeterminate Pulmonary Nodules |
5R01CA252964-05 |
|
Claire Zhu, Ph.D. |
| Grogan, Eric L |
Vanderbilt University Medical Center
United States |
Clinical Utility of a Combined Biomarker Approach to Diagnose Lung Cancer |
5U01CA152662-13 |
|
Guillermo Marquez, Ph.D. |
| Groninger, J. Hunter |
Medstar Health Research Institute
United States |
Cognitive behavioral theory-assisted virtual reality for chronic cancer pain (VR-CAN): device prototype development and feasibility testing |
1R21CA299799-01 |
|
Brennan Streck, Ph.D., RN, M.P.H. |
| Gross, Howard M |
Dayton Clinical Oncology Program
United States |
Dayton Clinical Oncology Program |
5UG1CA189957-11 |
|
Vanessa A. White, M.P.H. |
| Grossman, Douglas |
University Of Utah
United States |
Electrical impedance dermography as a biomarker for basal and squamous cell carcinoma |
1R21CA289101-01A1 |
|
Nick Hodges, Ph.D. |
